期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

套细胞淋巴瘤诊断与治疗中国专家共识(2016年版) 被引量：35

原文传递
导出
摘要 套细胞淋巴瘤(mantlecelllymphoma,MCL)是一种B细胞淋巴瘤亚类,占非霍奇金淋巴瘤(NHL)的6%~8%。由于其独特的组织形态学、免疫表型及细胞遗传学特征而广受关注。随着研究的深入,MCL的生物学行为、诊断标准、治疗原则等均已较成熟。
作者 中国抗癌协会血液肿瘤专业委员会 中华医学会血液学分会白血病淋巴瘤学组 中国抗淋巴瘤联盟 邱录贵 马军 易树华 徐卫 Hematology Oncology Committee of China Anti-Cancer Association;Leukemia&Lymphoma GroupSociety of Hematology at Chinese Medical Association;Union China Lymphoma for Investigators;Qiu Lugui;Ma Jun(不详;Institute ofHematology&Blood Disease Hospital,CAMS&300020;Harbin Institute ofHematology&Oncology,Harbin 150010,China)
机构地区 不详 中国医学科学院北京协和医学院血液学研究所、血液病医院 哈尔滨血液病肿瘤研究所 南京医科大学第一附属医院
出处 《中华血液学杂志》 CAS CSCD 北大核心 2016年第9期735-741,共7页 Chinese Journal of Hematology
基金 国家科技支撑计划(2014BAI09812)
关键词 套细胞淋巴瘤 诊断标准 治疗原则 非霍奇金淋巴瘤 专家 中国 B细胞淋巴瘤 组织形态学
分类号 R733.4 [医药卫生—肿瘤]
  • 相关文献

参考文献35

  • 1Swerdlow SH, Campo E, Harris NL, et al. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissue. 4th ed. Lyon:IARC Press, 2008:ednp 194-195.
  • 2Fan L, Miao Y, Wu Y J, et al. Expression patterns of CD200 and CD148 in leukemic B-cell chronic lymphoproliferative disorders and their potential value in differential diagnosis [J]. Leuk Lym- phoma, 2015, 56 (12):3329-3335.
  • 3易树华,李增军,王慧君,刘薇,吕瑞,于珍,齐军元,邱录贵.260例CD5+慢性B淋巴增殖性疾病患者免疫表型分析[J].中华血液学杂志,2014,35(4):337-341. 被引量：8
  • 4Salaverria I, Royo C, Carvajal-Cuenca A, et al. CCND2 rearrangements are the most frequent genetic events in cyclin D1 (-) mantle cell lymphoma[J]. Blood, 2013, 121(8):1394-1402.
  • 5Fu K, Weisenburger DD, Greiner TC, et al. Cyclin Dl-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling[J]. Blood, 2005, 106(13):4315-4321.
  • 6Royo C, Salaverria I, Hartmann EM, et al. The complex landscape of genetic alterations in mantle cell lymphoma [J]. Semin Cancer Biol, 2011, 21 (5):322-334.
  • 7Yi S, Zou D, Li C, et al. High incidence of MYC and BCL2abnormalities in mantle cell lymphoma, although only MYC abnormality predicts poor survival [ J] Oncotarget, 2015, 6 (39) : 42362-42371.
  • 8Fernfindez V, Salamero O, Espinet B, et al. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma [J]. Cancer Res, 2010, 70 (4):1408- 1418.
  • 9Rule SA, Poplar S, Evans PA, et al. Indolent mantle-cell lympho- ma: immunoglobulin variable region heavy chain sequence anal- ysis reveals evidence of disease 10 years prior to symptomatic clinical presentation [J]. J Clin Oncol, 2011, 29 (15) :e437-439.
  • 10Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neo- plasms [J]. Blood, 2016, 127 (20):2375-2390.

二级参考文献17

  • 1姚建新,李建勇.126例慢性淋巴细胞白血病免疫表型分析[J].中国血液流变学杂志,2006,16(3):367-369. 被引量：6
  • 2Swerdlow SH, Harris NL, Jaffe ES, et al. WHO classification of tumours of haematopoietic and lymphoid tissues [M]. Lyon: IARC, 2008.
  • 3Cro L, Guffanti A, Colombi prognostic significance of a M, et al. Diagnostic role and simplified immunophenotypic classification of mature B cell chronic lymphoid leukemias [J]. Leukemia, 2003, 17( 1 ): 125-132.
  • 4Tworek JA, Singleton TP, Schnitzer B, et al. Flow cytometric and immunohistochemical analysis of small lymphocytic lymphoma, mantle cell lymphoma, and plasmacytoid small lymphocytic lymphoma [J]. Am J Clin Pathol, 1998, 110 (5): 582-589.
  • 5Matutes E, Owusu-Ankomah K, Morilla R, et al. The immuno- logical profile of B-cell disorders and proposal of a scoring sys- tem for the diagnosis of CLL[J]. Leukemia, 1994, 8(10): 1640- 1645.
  • 6Kraus TS, Sillings CN, Saxe DF, et al. The role of CDllc ex- pression in the diagnosis of mantle cell lymphoma [J]. Am J Clin Pathol, 2010, 134(2): 271-277.
  • 7Gao J, Peterson L, Nelson B, et al. Immunophenotypic varia- tions in mantle cell lymphoma[J]. Am J Clin Pathol, 2009, 132 (5): 699-706.
  • 8Medd PG, Clark N, Leyden K, et al. A novel scoring system combining expression of CD23, CD20, and CD38 with platelet count predicts for the presence of the t (11;14) translocation of mantle cell lymphoma [J]. Cytometry B Clin Cytom, 2011, 80 (4): 230-237.
  • 9Jevremovic D, Dronca RS, Morice WG, et al. CD5 + B-cell lymphoproliferative disorders: Beyond chronic lymphocytic leukemia and mantle cell lymphoma [J]. Leuk Res, 2010, 34 (9): 1235-1238.
  • 10Dronca RS, Jevremovic D, Hanson CA, et al. CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entity [J]. Cytometry B Clin Cytom, 2010, 78 Suppl 1: S35-41.

共引文献74

同被引文献157

引证文献35

二级引证文献77

中华血液学杂志
2016年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部